Crossmark

Correction: Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway

Crossref DOI link: https://doi.org/10.1038/s41388-020-01440-7

Published Online: 2020-09-07

Published Print: 2020-10-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Qingqing

Huang, Tingting

Jiang, Zhiyuan

Ge, Chao

Chen, Xiaoxia

Zhang, Lili

Zhao, Fangyu

Zhu, Miaoxin

Chen, Taoyang

Cui, Ying

Li, Hong

Yao, Ming

Li, Jinjun

Tian, Hua https://orcid.org/0000-0002-2316-1953
License Information

Text and Data Mining valid from 2020-09-07

Version of Record valid from 2020-09-07
More Information

Article History

First Online: 7 September 2020

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below